This is a Reach announcement and the
information contained is not considered to be material or to have a
significant impact on management's expectations of the Company's
performance. Reach is an investor communication service aimed at
assisting listed and unlisted (including AIM quoted) companies to
distribute non-regulatory news releases into the public domain.
Information required to be notified under the AIM Rules for
Companies, Market Abuse Regulation or other regulation would be
disseminated as an RNS regulatory announcement and not on
Reach.
4 October
2024
MicroSalt plc
("MicroSalt®" or the "Company")
Microsalt Announces Significant Expansion of
Global Patent Portfolio
MicroSalt plc (AIM:
SALT), a leading provider of full-flavour,
natural salt with approximately 50% less sodium, is pleased to announce multiple developments in its patent
portfolio worldwide.
The Company received a Certificate
of Invention Patent in China for its patent application entitled
"Improved Low Sodium Salt Compositions," now issued as Chinese
Patent No. CN114206133.
In addition, on September 4, 2024,
the Company received a Notice of Allowance in Mexico for its
Mexican Patent Application No. MX2022001611, entitled "Improved Low
Sodium Salt Composition." The Company anticipates a Mexican Patent
to issue after payment of final issuance and initial annuity
fees.
On August 19, 2024, the Australian
Patent Office accepted the Company's Australian Patent Application
No. AU2020326597, entitled "Improved Low Sodium Salt Composition,"
initiating a three-month opposition period. If the accepted
application is not opposed, the Company anticipates an Australian
patent to issue after the end of the three-month opposition
period.
The Chinese Patent, allowed Mexican
Patent Application, and accepted Australian patent application all
claim priority to United States patent applications that issued as
United States Patent No. 11,992,034, entitled "Low Sodium Salt
Composition," and all are directed to a low sodium salt composition
comprising salt adhered to a carrier particle produced according to
a claimed process.
The Company has additional pending
patent applications directed to its a low sodium salt composition
comprising salt adhered to a carrier particle produced according to
a claimed process in Canada, Hong Kong, Chile, Japan, Europe,
Brazil, India, and Russia.
Rick Guiney, CEO of MicroSalt
commented: "We are very pleased
to witness the expansion of our intellectual property portfolio
into some of the largest sodium markets in the world. We have made
commercial inroads with customers in Asia, Europe and Australia and
we see this development as very timely".
About MicroSalt
plc
MicroSalt® is dedicated to innovating food technology
solutions that enable people to live longer, healthier, and happier
lives. Its patented low-sodium salt delivers natural salt with
approximately 50% less sodium and may be used by both consumers and
food manufacturers to decrease the amount of sodium in their food.
SaltMe! chips are produced using MicroSalt®, a patented innovative
salt technology which is 100% natural, non-GMO, gluten free, and
Kosher certified, that does not contain any potassium chloride. To
learn more about MicroSalt Inc. and MicroSalt® products, please
visit https://microsalt.co, follow on X @microSaltPLC or
contact:
MicroSalt
plc
|
Via Flagstaff
|
Rick Guiney, CEO
|
|
|
|
Flagstaff
PR (Financial IR/FPR)
|
+44 (0)20 7129 1474
|
Tim Thompson / Alison Allfrey / Anna
Probert
microsalt@flagstaffcomms.com
|
|
|
| |
Notes to Editors
MicroSalt® produces a patented
full-flavour, low-sodium salt for food manufacturers and
consumers.
MicroSalt is a major potential
disruptor in the food market, thanks to its micron sized particles
which deliver the same sense of saltiness to a wide range of foods
but with approximately 50% less sodium. Excess sodium consumption
is a significant contributor to cardiovascular disease and
MicroSalt's solution meets the rising demand for healthier
alternatives to traditional salt. The WHO has set a
target for reducing global sodium intake by 30% by 2025, which it
estimates will save 7 million lives by 2030.
Each year, cardiovascular disease
costs the UK £19 billion - if the average salt intake was reduced
by one gram per day, it has been estimated that 4,147 lives and
£288 million would be saved each year in the UK. As a nation, the
UK consumes 183 million kilograms of salt each year, and 70% of the
typical person's sodium intake is hidden in processed
foods.
Operational since 2018, MicroSalt
uses a patent-protected technology which helps create high barriers
to entry within the reduced-sodium salt market.
The Directors believe that MicroSalt
is well positioned to capture growth in the low sodium market,
which is expected to grow exponentially, and that there is also
scope to enter the larger salt market.
ENDS